Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person7
BeOne Medicines Ltd.
Company
Medi UK Ltd
Company · 02110690
Disc Medicine, Inc.
Company
MediWound Ltd.
Company
Medline Industries Ltd
Company · 03238147
Medicus Pharma Ltd.
Company
Editas Medicine, Inc.
Company
Primary record14
BeOne Medicines Ltd. filed 8-K
Item 2.02. Results of Operations and Financial Condition. On November 5, 2026 , BeOne Medicines Ltd. announced its financial results for the three months ended September 30, 2026. A copy of the press release is attached
BeOne Medicines Ltd. filed 4
SEC form 4 filed by BeOne Medicines Ltd. (CIK 1651308) on 2026-10-29.
BeOne Medicines Ltd. filed 4
SEC form 4 filed by BeOne Medicines Ltd. (CIK 1651308) on 2026-10-15.
BeOne Medicines Ltd. filed 4
SEC form 4 filed by BeOne Medicines Ltd. (CIK 1651308) on 2026-10-02.
BeOne Medicines Ltd. filed 4
SEC form 4 filed by BeOne Medicines Ltd. (CIK 1651308) on 2026-09-30.
BeOne Medicines Ltd. filed SCHEDULE 13D/A
("SEC") on August 5, 2026 plus 526,890 Ordinary Shares underlying 263,445 Share Options which were received by each of Michael Goller and Ranjeev Krishana, as compensation for their service on the Board, and 399,984 Ordi
BeOne Medicines Ltd. filed 4
SEC form 4 filed by BeOne Medicines Ltd. (CIK 1651308) on 2026-09-10.
BeOne Medicines Ltd. filed 4
SEC form 4 filed by BeOne Medicines Ltd. (CIK 1651308) on 2026-09-03.
BeOne Medicines Ltd. filed 4
SEC form 4 filed by BeOne Medicines Ltd. (CIK 1651308) on 2026-08-27.
BeOne Medicines Ltd. filed 8-K
Item 2.02. Results of Operations and Financial Condition. On August 26, 2026, BeOne Medicines Ltd. (the Company ) filed its 2026 Interim Report for the six months ended June 30, 2026 (the STAR Interim Report ) with the S
Zymeworks Inc. filed 8-K
ITEM 7.01 REGULATION FD DISCLOSURES On August 25, 2026, Zymeworks Inc. (“Company”) issued a press release announcing that its partner, Jazz Pharmaceuticals, has received U.S. Food and Drug Administration (“FDA”) approval
BeOne Medicines Ltd. filed 4
SEC form 4 filed by BeOne Medicines Ltd. (CIK 1651308) on 2026-08-13.
BeOne Medicines Ltd. filed 4
SEC form 4 filed by BeOne Medicines Ltd. (CIK 1651308) on 2026-08-12.
BeOne Medicines Ltd. filed 8-K
Item 2.02. Results of Operations and Financial Condition. On August 5, 2026 , BeOne Medicines Ltd. announced its financial results for the three months ended June 30, 2026. A copy of the press release is attached hereto